These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3730459)

  • 21. Depression and dexamethasone suppression testing in children and adolescents.
    Emslie GJ; Weinberg WA; Rush AJ; Weissenburger J; Parkin-Feigenbaum L
    J Child Neurol; 1987 Jan; 2(1):31-7. PubMed ID: 3624827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of stress on the dexamethasone suppression test.
    Ceulemans DL; Westenberg HG; van Praag HM
    Psychiatry Res; 1985 Mar; 14(3):189-95. PubMed ID: 3858891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry.
    Am J Psychiatry; 1987 Oct; 144(10):1253-62. PubMed ID: 3310667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diagnostic distribution of dexamethasone non-suppressors.
    Mellsop GW; Cooke RR; Vijayasenan ME
    Aust N Z J Psychiatry; 1985 Jun; 19(2):168-71. PubMed ID: 3863606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression.
    Holsboer F; von Bardeleben U; Wiedemann K; Müller OA; Stalla GK
    Biol Psychiatry; 1987 Feb; 22(2):228-34. PubMed ID: 3028512
    [No Abstract]   [Full Text] [Related]  

  • 27. The dexamethasone suppression test in adolescent psychiatric inpatients.
    Targum SD; Capodanno AE
    Am J Psychiatry; 1983 May; 140(5):589-91. PubMed ID: 6846588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stress lymphocytes and the dexamethasone suppression test in major depressive disorders.
    Miyauchi K; Hirata-Hibi M; Hashimoto M; Hosokawa K
    Biol Psychiatry; 1989 Apr; 25(8):1021-8. PubMed ID: 2720015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexamethasone suppression test in psychiatric patients with psychoactive substance dependence.
    Olivera AA; Fero D; Scibilia J
    Am J Drug Alcohol Abuse; 1991 Sep; 17(3):295-305. PubMed ID: 1928023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further investigation of the dexamethasone suppression test in affective illnesses: relationship to clinical diagnosis and therapeutic response.
    Mendlewicz J; Hubain PP; Koumakis C
    Neuropsychobiology; 1984; 12(1):23-6. PubMed ID: 6514175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma dexamethasone concentrations and the dexamethasone suppression test.
    Ritchie JC; Belkin BM; Krishnan KR; Nemeroff CB; Carroll BJ
    Biol Psychiatry; 1990 Jan; 27(2):159-73. PubMed ID: 2294980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline plasma cortisol and dexamethasone test in unselected psychiatric inpatients.
    Volsan O; Berzewski H
    Psychopathology; 1985; 18(4):186-97. PubMed ID: 4089117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The dexamethasone suppression test in children and adolescents: a review and a controlled study.
    Dahl RE; Kaufman J; Ryan ND; Perel J; al-Shabbout M; Birmaher B; Nelson B; Puig-Antich J
    Biol Psychiatry; 1992 Jul; 32(2):109-26. PubMed ID: 1420629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consistency of pituitary-adrenocortical function across multiple psychiatric hospitalizations.
    Brown WA; Haltzman SD; Fruzzetti A; Keitner GI; Norman W; Miller I
    Psychiatry Res; 1986 Jul; 18(3):203-8. PubMed ID: 3749382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DST studies in psychotic depression: a meta-analysis.
    Nelson JC; Davis JM
    Am J Psychiatry; 1997 Nov; 154(11):1497-503. PubMed ID: 9356556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility.
    Carroll BJ; Feinberg M; Greden JF; Tarika J; Albala AA; Haskett RF; James NM; Kronfol Z; Lohr N; Steiner M; de Vigne JP; Young E
    Arch Gen Psychiatry; 1981 Jan; 38(1):15-22. PubMed ID: 7458567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dexamethasone suppression test and quantitative cerebral anatomy in depression.
    Coffey CE; Wilkinson WE; Weiner RD; Ritchie JC; Aque M
    Biol Psychiatry; 1993 Mar; 33(6):442-9. PubMed ID: 8490071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dexamethasone effects on numbers of cells in lymphocyte subpopulations: changes associated with major depression and DST nonsuppression.
    Pedersen CA; Folds JD; Evans DL
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):895-906. PubMed ID: 2813807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The DST and posttraumatic stress disorder.
    Kudler H; Davidson J; Meador K; Lipper S; Ely T
    Am J Psychiatry; 1987 Aug; 144(8):1068-71. PubMed ID: 3605429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility.
    Greden JF; Gardner R; King D; Grunhaus L; Carroll BJ; Kronfol Z
    Arch Gen Psychiatry; 1983 May; 40(5):493-500. PubMed ID: 6340634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.